Abstract
Organoselenium derivatives are recently attracting the interest of a number of research groups in relation to the wide range of Pharmacological properties that are currently under investigation. This generated a considerable proliferation of studies that in the last four years investigated several biological relevant effects for a number of different class of organoselenium compounds. The state of the art on the GPx-like derivatives will be here reported updating the review article published by Santi et al. in 2013 that cover the literature until early 2012. In addition, other biological activities not covered by that review will be reported focusing the interest on the most recent developments.
Keywords: Selenium, selenoproteins, glutathione, ROS, ebselen, GPx.
Graphical Abstract
Current Chemical Biology
Title:An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Volume: 9 Issue: 2
Author(s): Agata J. Pacuła, Francesca Mangiavacchi, Luca Sancineto, Eder J. Lenardão, Jacek Ścianowski and Claudio Santi
Affiliation:
Keywords: Selenium, selenoproteins, glutathione, ROS, ebselen, GPx.
Abstract: Organoselenium derivatives are recently attracting the interest of a number of research groups in relation to the wide range of Pharmacological properties that are currently under investigation. This generated a considerable proliferation of studies that in the last four years investigated several biological relevant effects for a number of different class of organoselenium compounds. The state of the art on the GPx-like derivatives will be here reported updating the review article published by Santi et al. in 2013 that cover the literature until early 2012. In addition, other biological activities not covered by that review will be reported focusing the interest on the most recent developments.
Export Options
About this article
Cite this article as:
Pacuła Agata J., Mangiavacchi Francesca, Sancineto Luca, J. Lenardão Eder, Ścianowski Jacek and Santi Claudio, An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”, Current Chemical Biology 2015; 9 (2) . https://dx.doi.org/10.2174/2212796810666160120220725
DOI https://dx.doi.org/10.2174/2212796810666160120220725 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Pulmonary Hypertension: Role of Combination Therapy
Current Vascular Pharmacology Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Helicobacter pylori: An Overview on Antimicrobials and Drug Delivery Systems for its Eradication
Current Drug Delivery Disturbed Tryptophan Metabolism in Cardiovascular Disease
Current Medicinal Chemistry Adiposity and Alzheimers Disease
Current Alzheimer Research Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension
Current Vascular Pharmacology Mechanisms and Medical Management of Exercise Intolerance in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design Potential Applications for Using Stem Cells in Spine Surgery
Current Stem Cell Research & Therapy Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?
Current Pharmaceutical Design Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Early Pathogenesis of Atherosclerosis: The Childhood Obesity
Current Pharmaceutical Design Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
Current Medicinal Chemistry